United States buys nearly all the remdesivir
The US Health Department has announced that it is buying almost all of the next three months’ production of the antiviral drug remdesivir from US company Gilead. Clinical trials suggest that the drug can speed up recovery from coronavirus infection in people with severe COVID-19, although it is still unknown whether the treatment can increase survival rates. Critics say the move undermines international efforts to fight the pandemic. "It so clearly signals an unwillingness to co-operate with other countries and the chilling effect this has on international agreements about intellectual-property rights,” says science-policy researcher Ohid Yaqub.
BBC News | 4 min read
.png)
No hay comentarios:
Publicar un comentario